claim
Clinical trials employing mesenchymal stem cells to treat chronic kidney disease face challenges including determining the optimal administration method, ensuring cell flourishing, tracking injected cells, preventing immunological rejection, improving homing and engraftment, and increasing immune acceptance.
Authors
Sources
- Cellular rejuvenation: molecular mechanisms and potential ... - Nature www.nature.com via serper
Referenced by nodes (2)
- chronic kidney disease concept
- mesenchymal stromal cells concept